Search Product
Structure Search
Search
Advantage Products
Location: Industrial Info
Genome scientist Venter financing 70000000 dollar development of anti-aging medicine
2014-08-02
来源:转载自第三方
American genome scientist Craig Venter (Craig Venter) said, has raised $70000000, to set up a new biological technology company, the company is committed to research and development of anti aging drugs.
Venter said today, has raised $70000000 from investors, to set up Human Longevity (hereinafter referred to as "HLI") company. HLI plans to create the world's largest genome project, a hitherto unknown genome database, human genotype, and covers the complete parasite and phenotype. HLI will use the information to explore cell therapy, in order to extend human life and improve the quality of life.
Dr Venter will become the new formed HLI company chairman and CEO, the X Prize Foundation's Peter Diamondys (Peter Diamandis) and Celgene Robert Khalil (Robert Hariri) two will serve as vice chairman.
Venter said, in the creation of the corresponding database, by way of information authorized to bio pharmaceutical industry to obtain income, and is dedicated to the study of a new generation of therapy and diagnosis methods. As the proactive type scientist, Dr Venter plan for sequencing by industrial scale, the company initially each year on the 40000 genome sequencing, the next step growth to 100000 a year.
Venter, Craig?
Craig? Venter, full name John Craig Venter, J. Craig Venter is usually written. In 1946 October was born in America Saline Lake City, is a biologist and entrepreneur. In 2000 July, Time magazine put him with the human genome project on behalf of Francis Collins also was chosen as the cover?. In 2007, he was selected to enter one of the most influential people in the world. In May the same year, an honorary degree from University of Arizona venter. In May 20, 2010, Craig? Venter announced the successful manufacture synthetic cell "Cynthia", has caused the global debate.
Craig? Dr Venter is Celera Genome Corporation (Celera Genomics) founder and former CEO, the company and the human genome project, and compete with commercial objective research program under his leadership, he has since become famous. But in 2002, the board of directors of the company, Celera dismiss.
At present, Venter Venter Institute is Craig? (J. Craig Venter Institute, established by TIGR) chairman, the Institute spans many different areas.
如果涉及转载授权,请联系我们。